Phase Transition Is Infrequent Among North American Adults With e-Antigen-Negative Chronic Hepatitis B and Low-Level Viremia-Reference-Cited by-同舟云学术

Phase Transition Is Infrequent Among North American Adults With e-Antigen-Negative Chronic Hepatitis B and Low-Level Viremia

Published:2019-10-24 Issue:11 Volume:114 Page:1753-1763
ISSN:0002-9270
Container-title:American Journal of Gastroenterology
language:en
Short-container-title:Am J Gastroenterol

Author:

Zhou Kali,Wahed Abdus S.,Cooper Stewart,Di Bisceglie Adrian M.,Fontana Robert J.,Ghany Marc G.,Khalili Mandana,Lok Anna S.,Perrillo Robert,Lee William M.,Lau Daryl T.Y.,Sterling Richard,Janssen Harry L.A.,Terrault Norah A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference38 articles.

1. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance;Terrault;Hepatology,2018

2. Liver fibrosis progression is uncommon in patients with inactive chronic hepatitis B: A prospective cohort study with paired transient elastography examination;Wong;J Gastroenterol Hepatol,2013

3. The role of serial measurement of serum HBV DNA levels in patients with chronic HBeAg(-) hepatitis B infection: Association with liver disease progression. A prospective cohort study;Zacharakis;J Hepatol,2008

4. Natural history of chronic HBV infection: Special emphasis on the prognostic implications of the inactive carrier state versus chronic hepatitis;Villa;Dig Liver Dis,2011

5. Follow-up and indications for liver biopsy in HBeAg-negative chronic hepatitis B virus infection with persistently normal ALT: A systematic review;Papatheodoridis;J Hepatol,2012

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Canadian Association for the Study of the Liver Single Topic Conference on Hepatitis B Virus: ‘Progress toward hepatitis B elimination in Canada’;Canadian Liver Journal;2024-08-28

2. Interferon-α could induce liver steatosis to promote HBsAg loss by increasing triglyceride level;Heliyon;2024-06

3. Hepatocellular carcinoma among patients with chronic hepatitis B in the indeterminate phase;Journal of Viral Hepatitis;2024-05-08

4. Should Indications for Antiviral Therapy for Hepatitis B Be Broadened to Include Immune-Tolerant Patients, Inactive Carriers, or Patients in the “Gray Zone”?;Current Hepatology Reports;2024-02-12

5. HBV-miR-3 is closely related to HBV replication and strongly predictive of HBeAg seroconversion in PegIFN-α treated patients;Scientific Reports;2024-01-17